International biotechnology conference in Strasbourg, France | 13 Nov 2013 - Printable Version +- Biotechnology Forums (https://www.biotechnologyforums.com) +-- Forum: Information (https://www.biotechnologyforums.com/forum-16.html) +--- Forum: Biotechnology Conferences and Events (https://www.biotechnologyforums.com/forum-18.html) +--- Thread: International biotechnology conference in Strasbourg, France | 13 Nov 2013 (/thread-2526.html) |
International biotechnology conference in Strasbourg, France | 13 Nov 2013 - mtwalsh01 - 10-11-2013 Biotechnology: The Biopharmaceutical Challenge from Process Development to Future Facilities Organisers: International Society for Pharmaceutical Engineering (ISPE) Dates: 13th-14th November 2013 Location: Hilton Strasbourg Hotel, Strasbourg, France Website: http://www.ispe.org/2013-biotechnology-eu-conference The website gives all the necessary information on fees, registration, conference agenda, hotel, exhibitions and other important facts. Early bird registration is available until 18th October. Purpose of the conference The purpose is to explore and educate on current technologies and regulatory requirements. Techniques will be provided for the evaluation and implementation of cutting-edge technologies. In-depth discussion will focus on cost-effective, flexible, sustainable manufacturing facilities design and implementation. Who should attend? Pharmaceutical and biopharmaceutical industry mid- and senior-level professionals Pharmaceutical and biopharmaceutical industry suppliers Pharmaceutical and biopharmaceutical industry regulators Process development scientists Technology transfer managers Manufacturing managers Pharmaceutical and biopharmaceutical industry engineers Quality assurance and quality control professionals Risk assessors Academics Speakers: Keynote speaker: Britt Petty, Director MEF, Biogen Idec Others: Robert Dream, Principal, HDR COMPANY LLC; Miriam Monge, Vice President Sales & Marketing, Biopharm Services Ltd; Dave Wolton, Biotechnology Consultant, PM Group; Aurore Lahille, New Technology Manager, Merck Biodevelopment; Katell Mignot, Head of Application Specialist SE & NEMEA, Sartorius Stedim Biotech; Paul Bird, Head of Development Engineering, Fujifilm Diosynth Biotechnologies; Philippe Ronse, Director, Head Technical Lifecycle Management, GlaxoSmithKline Vaccines; Kai Touw, Process Engineer USP, Crucell / J&J; Wiebe van Vuure, Process Engineer DSP Development, Crucell / J&J; Hitto Kaufmann, Vice President Process Science, Boehringer Ingelheim; Dr. Olivier Cochet, Director Industrial Biotechnology, Institut de Recherche Pierre-Fabre; Peter Rogge, Vice President USP Production, Rentschler Biotechnologie GmbH; Thorsten Kimmel, Senior Process Engineer, F. Hoffmann-La Roche; Mark von Stwolinski, Vice President of Architectural Services, CRB Consulting Engineers, Inc.; Robin Payne, Facilitator, BioPhorum; Daniel Abrahamsson, Validation Engineer Consultant, NNE Pharmaplan Topics to be covered in conference sessions: New and Enabling Technologies Driving Efficiency through Product Lifecycle Plant Tours (Millipore and Octapharma) Facility Design Regulatory Developments and Focus Facility Efficiency - Regulatory, GMP Challenges Who are the organisers? IPSE are a not-for-profit association concerned with the life-cycle of pharmaceuticals in terms of scientific, technical and regulatory advancement. It was founded in 1980 beginning with membership of engineers in North America and has gradually expanded to include representatives from many different types of pharmaceutical professionals. It now has 22000 members in 90 countries and is committed to keeping professionals in the pharmaceutical and biopharmaceutical industries informed of technological and regulatory trends and developments and to advancing the educational and technical efficiency of its members. |